Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma

Six patients with asthma (American Thoracic Society (ATS) criteria), maintained on inhaled beta 2-agonists alone, were treated with inhaled corticosteroid (budesonide 400 micrograms b.d.) for a period of three months. Prior to steroid therapy, baseline spirometry, bronchodilator response and bronchial hyperresponsiveness were documented and endobronchial biopsies were obtained for immunopathological analysis. Frozen sections of the biopsies were investigated using immunoperoxidase methods, with a panel of monoclonal antibodies selected to reveal the presence and distribution of lymphocyte and macrophage subsets and HLA-DR expression. After three months the studies were repeated. Studies before steroid therapy revealed a T-cell-dominated inflammation in the bronchial wall of all subjects. Baseline airway obstruction, median (range) forced expiratory volume in one second (FEV1) 78.5 (61-109)% of predicted, with a significant bronchodilator response 20.8 (14-33)% and bronchial hyperresponsiveness to histamine geometric mean (SD) PC20FEV1 0.69 (2.5) mg was documented. Steroid therapy caused a significant reduction in bronchial hyperresponsiveness to histamine, with an increase in geometric mean PC20FEV1 to 2.22 (3.2) mg post steroid (p less than 0.03). Concurrent with a reduction in bronchodilator response and an increase in spirometric variables (improved forced midexpiratory flow (FEF25-75) p less than 0.03), there were marked reductions observed in the overall numbers of T-lymphocytes (CD 2, 5, 8), the numbers of CD45RO+ T-cells, and the numbers of macrophages (RFD1+) with the phenotype of antigen presenting cells. In all six subjects, reductions in the quantitative expression of HLA-DR molecules were also seen.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Stoeck, R. Riedel, G. Hochhaus, D. Hafner, J. M. Masso, B. Schmidt, A. Hatzelmann, D. Marx, and D. S. Bundschuh In Vitro and in Vivo Anti-Inflammatory Activity of the New Glucocorticoid Ciclesonide J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 249 - 258. [Abstract] [Full Text]

				E.-B. Haddad, S. L. Underwood, D. Dabrowski, M. A. Birrell, K. McCluskie, C. H. Battram, M. Pecoraro, M. L. Foster, and M. G. Belvisi Critical Role for T Cells in Sephadex-Induced Airway Inflammation: Pharmacological and Immunological Characterization and Molecular Biomarker Identification J. Immunol., March 15, 2002; 168(6): 3004 - 3016. [Abstract] [Full Text] [PDF]

				L. Xu, R. Olivenstein, J. G. Martin, and W. S. Powell Inhaled budesonide inhibits OVA-induced airway narrowing, inflammation, and cys-LT synthesis in BN rats J Appl Physiol, November 1, 2000; 89(5): 1852 - 1858. [Abstract] [Full Text] [PDF]

				B. LAMKHIOUED, E. A. GARCIA-ZEPEDA, S. ABI-YOUNES, H. NAKAMURA, S. JEDRZKIEWICZ, L. WAGNER, P. M. RENZI, Z. ALLAKHVERDI, C. LILLY, Q. HAMID, et al. Monocyte Chemoattractant Protein (MCP)-4 Expression in the Airways of Patients with Asthma . Induction in Epithelial Cells and Mononuclear Cells by Proinflammatory Cytokines Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 723 - 732. [Abstract] [Full Text] [PDF]

				J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745. [Full Text]

				C. T. LEONARD, P. M. SOCCAL, L. SINGER, G. J. BERRY, J. THEODORE, P. G. HOLT, R. L. DOYLE, and G. D. ROSEN Dendritic Cells and Macrophages in Lung Allografts . A Role in Chronic Rejection? Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1349 - 1354. [Abstract] [Full Text]

				J. L Faul, C. T Leonard, C. M Burke, V. J Tormey, and L. W Poulter Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time Thorax, September 1, 1998; 53(9): 753 - 761. [Abstract] [Full Text]

				P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]

				T. E. Lawrence, L. L. Millecchia, and J. S. Fedan Fluticasone Propionate and Pentamidine Isethionate Reduce Airway Hyperreactivity, Pulmonary Eosinophilia and Pulmonary Dendritic Cell Response in a Guinea Pig Model of Asthma J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 222 - 227. [Abstract] [Full Text]

				L. M. FABBRI, G. CARAMORI, B. BEGHÉ, A. PAPI, and A. CIACCIA Physiologic Consequences of Long-term Inflammation Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 195 - 198. [Full Text]

				P. J. Barnes Inhaled Glucocorticoids for Asthma N. Engl. J. Med., March 30, 1995; 332(13): 868 - 875. [Full Text] [PDF]